TrialIndian journal of pharmacology

Denosumab biosimilar in postmenopausal osteoporotic women: A randomized, assessor-blind, active-controlled clinical trial.

Inderjeet Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.